Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer made ...
Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...
16h
Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030
Industry growth is driven by demand for cost-effective generics and emerging market access Paclitaxel Injection Market Paclitaxel Injection Market Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The ...
Pharmaceutical company Pfizer said Friday it was blocking use of its drugs in lethal injections, which means all federally-approved drugmakers whose medications could be used for executions have now ...
The company has not disclosed pricing or a launch timeline. The approval also comes as Novo Nordisk's Wegovy nears patent expiry later this month, potentially paving the way for lower-cost copycat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results